Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cell-Free Cord Blood Derived Microvesicles in Type 1 Diabetes Mellitus
NCT02138331Phase 3Unknown
- Sponsor
- General Authority for Teaching Hospitals and Institutes
- Start
- Apr 2014
- Primary completion
- Jul 2014
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of mesenchymal stem cell exosomes in type 1 diabetes mellitus (T1D), sponsored by General Authority for Teaching Hospitals and Institutes. Status: unknown.
02
Drugs
mesenchymal stem cell exosomes
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02138331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138331.